2160 News & Analysis

GNI Group (2160) to Acquire Ayumi Pharmaceutical for ¥44.8 Billion

GNI Group (2160) has announced its intention to acquire Ayumi Pharmaceutical for a total of ¥44.8 billion. This acquisition is significant as it expands GNI's portfolio in the pharmaceutical sector. The deal is expected to enhance GNI's capabilities in drug development and potential market reach. Investors will be watching how this strategic move impacts GNI's revenue and operational synergies moving forward.